Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/07/2014WO2014120808A1 Pyridone amides as modulators of sodium channels
08/07/2014WO2014120800A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120799A1 Synthetic lipochitooligosaccharides for improvement of plant growth and yield
08/07/2014WO2014120790A1 Small molecules to block signaling pathway
08/07/2014WO2014120789A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120786A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120784A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120783A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120774A1 Fungal iron acquisition inhibitors and uses thereof
08/07/2014WO2014120683A1 Small-molecule inhibitors targeting g-protein-coupled rho guanine nucleotide exchange factors
08/07/2014WO2014120658A1 Fused multicyclic 3-amino-5,6-dihydro-2h-1,4-thiazine derivatives and their use as beta-secretase inhibitors
08/07/2014WO2014120654A1 Benzoquinolone inhibitors of vmat2
08/07/2014WO2014120587A1 Ureteral stent with drug-releasing structure
08/07/2014WO2014120538A1 PPARγ AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS
08/07/2014WO2014120346A1 Factor ixa inhibitors
08/07/2014WO2014120293A1 Ophthalmic formulations
08/07/2014WO2014120021A1 A combination medicament comprising phenylephrine and paracetamol
08/07/2014WO2014119947A1 Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as cetp inhibitors
08/07/2014WO2014118809A1 Pharmaceutical composition with linezolid
08/07/2014WO2014118808A2 Ticagrelor solid dispersion
08/07/2014WO2014118807A1 A novel process for the preparation of sorafenib tosylate form iii
08/07/2014WO2014118805A1 Process for the preparation of ivacaftor and solvates thereof
08/07/2014WO2014118796A1 An in-situ process for the preparation of highly pure montelukast sodium
08/07/2014WO2014118740A1 Macrocyclic lactone derivatives and uses thereof
08/07/2014WO2014118737A1 Erlotinib salts
08/07/2014WO2014118735A1 A formulation, e.g. for use in the treatment of flu and colds
08/07/2014WO2014118721A1 Pharmaceutical oral solid dosage forms comprising valsartan and nebivolol
08/07/2014WO2014118677A1 Compositions and methods for counteracting factor xa inhibition
08/07/2014WO2014118618A1 Benzomorphan analogs and the use thereof
08/07/2014WO2014118578A1 Composition comprising a tnfr agonist and at least one thioredoxin inhibitor for use in the treatment of carcinoma.
08/07/2014WO2014118532A1 Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy
08/07/2014WO2014118530A1 Multi-component crystalline particles for inhalation therapy
08/07/2014WO2014118527A1 Topical composition comprising dantrolene and/or azumolene
08/07/2014WO2014118438A1 Composition for binding aldehydes in the mouth
08/07/2014WO2014118361A1 Composition for treatment of pathogens that are resistant to tetracyclines
08/07/2014WO2014118307A1 Salt polymorph of thioxanthene-9-ylidene-1-methyl piperidine acid addition salts as antimigraine compounds
08/07/2014WO2014118272A1 Antimir-122 oligonucleotide carbohydrate conjugates
08/07/2014WO2014118271A1 Compositions for oral administration having a beneficial effect on cartilage disease, osteoarthritis and joint disease with an inflammatory component
08/07/2014WO2014118267A1 Lna oligonucleotide carbohydrate conjugates
08/07/2014WO2014118229A1 Substituted thienopyrimidines and pharmaceutical use thereof
08/07/2014WO2014118226A1 Substituted pyrazolopyrimidinylamino-indazoles
08/07/2014WO2014118206A1 Foam cell specific liver x receptor (lxr) alpha agonist as pharmaceutically active agent
08/07/2014WO2014118195A1 Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
08/07/2014WO2014118186A1 Amino-substituted isothiazoles
08/07/2014WO2014118135A1 Amidoimidazopyridazines as mknk-1 kinase inhibitors
08/07/2014WO2014118133A1 Pyridine derivatives as soft rock inhibitors
08/07/2014WO2014118112A1 Pharmaceutical composition comprising erlotinib hydrochloride
08/07/2014WO2014118097A1 Compositions comprising 15-ohepa and methods of using the same
08/07/2014WO2014118090A1 Periodontal disease treatment
08/07/2014WO2014118039A1 Radiolabeled compounds
08/07/2014WO2014117999A1 Compositions and methods for treating chronic inflammation and inflammatory diseases
08/07/2014WO2014117948A1 Novel substituted condensed pyrimidine compounds
08/07/2014WO2014117947A1 4-amino substituted condensed pyrimidine compounds as pde4 inhibitors
08/07/2014WO2014117919A1 Positive allosteric modulators of mglur3
08/07/2014WO2014117863A1 Salt polymorph of thioxanthene - 9 - ylidene - 1 - methyl piperidine acid addition salts as antimigraine compounds
08/07/2014WO2014117755A1 Antibiotic preparation and use thereof
08/07/2014WO2014117741A1 Heterocyclo compounds as apoptotic inducers and uses thereof
08/07/2014WO2014117710A1 Commands and method of treating cancer via rho pathway
08/07/2014WO2014117274A1 Imidazopyridine compounds and uses thereof
08/07/2014WO2014117265A1 Liquid menthol compositions
08/07/2014WO2014105777A8 Cobicostat dichlohydrate salt
08/07/2014WO2014093988A3 Methods and compositions for inhibiting cnksr1
08/07/2014WO2014093583A3 Synthetic methods for preparing 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, other salt forms of this compound and intermediates thereof
08/07/2014WO2014093225A3 Polycyclic compounds and methods of making and using the same
08/07/2014WO2014089296A3 Functionalized benzamide derivatives as antiviral agents against hbv infection
08/07/2014WO2014081392A8 Composition and method for respiratory delivery of dye for visualisation of eye
08/07/2014WO2014074940A9 Crystalline forms of (1s)-1-[5-({3-[(2-methylpyridin-3-yl)oxy]-5-(pyridin-2-ylsulfanyl)pyridin-2-yl}amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diol
08/07/2014WO2014073946A3 Use of betalains and derivatives thereof for the production of a drug for the treatment, prevention, regulation and control of hepatopathies, diseases with inflammatory infiltrate, necrosis and for the modificaiton of lipid deposits
08/07/2014WO2014065848A3 Compounds for treating papilloma virus infection
08/07/2014WO2014064410A3 Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane
08/07/2014WO2014060493A3 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
08/07/2014WO2014060375A3 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
08/07/2014WO2013142817A3 Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
08/07/2014WO2013111013A8 Methods for treating alzheimer's disease by administering certain synthetic compounds
08/07/2014WO2011123751A3 Heterocyclic compounds and their use as pi3k inhibitors
08/07/2014US20140221972 Method for treating glaucoma
08/07/2014US20140221961 Insertable medical device for delivering nano-carriers of mitomycin (and its analogues) to a target site, and methods for preparing and using the same
08/07/2014US20140221943 Applicator system for applying a viscous liquid to the human skin
08/07/2014US20140221906 Patch system for the treatment of warts and method for same
08/07/2014US20140221904 Implant for living body, method for adjusting drug release density from the implant, and method for treatment using the implant
08/07/2014US20140221501 Therapeutic foam
08/07/2014US20140221497 Methods of Using Rapid-Onset Selective Serotonin Reuptake Inhibitors for Treating Sexual Dysfunction
08/07/2014US20140221496 Method of Diagnosis or Prognosis of a Neoplasm Comprising Determining the Level of Expression of a Protein in Stromal Cells Adjacent to the Neoplasm
08/07/2014US20140221494 Medicament
08/07/2014US20140221493 Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
08/07/2014US20140221491 In Vivo Method for Treating, Inhibiting, and/or Prophylaxis of Cancer, such as Pancreatic Cancer
08/07/2014US20140221490 Methods of treating pain
08/07/2014US20140221489 Infusion and Injection Solution of Levodopa
08/07/2014US20140221488 Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
08/07/2014US20140221487 Use Of Xanthophyll Carotenoids To Improve Visual Performance And Neural Efficiency
08/07/2014US20140221486 Methods of reducing apolipoprotein c-iii
08/07/2014US20140221484 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
08/07/2014US20140221483 GIP Elevation Inhibitor
08/07/2014US20140221482 Triheptanoin for the treatment of glucose transport 1 deficiency
08/07/2014US20140221480 Methods of managing brain inflammation
08/07/2014US20140221474 Method and Formulation for Chemical Peeling
08/07/2014US20140221472 Use of myricetin or derivatives thereof as a cathepsin k inhibitor
08/07/2014US20140221471 Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
08/07/2014US20140221469 Phytocannabinoids for use in the treatment of cancer
08/07/2014US20140221467 Metformin derivatives for treating diabetes and diabetes complications
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 7860